Technical Analysis for BBLG - Bone Biologics Corp
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| New Uptrend | Bullish | -14.55% | |
| Upper Bollinger Band Walk | Strength | -14.55% | |
| Inside Day | Range Contraction | -14.55% | |
| Wide Bands | Range Expansion | -14.55% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 1 day ago |
| Up 3% | 1 day ago |
| Fell Below 50 DMA | 1 day ago |
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/13/2024
Bone Biologics Corp Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biopharmaceutical Clinical Medicine Surgery Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease Spinal Fusion Applications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 55.12 |
| 52 Week Low | 1.46 |
| Average Volume | 61,685 |
| 200-Day Moving Average | 3.99 |
| 50-Day Moving Average | 1.94 |
| 20-Day Moving Average | 1.80 |
| 10-Day Moving Average | 1.97 |
| Average True Range | 0.29 |
| RSI (14) | 48.98 |
| ADX | 27.9 |
| +DI | 34.06 |
| -DI | 14.39 |
| Chandelier Exit (Long, 3 ATRs) | 2.28 |
| Chandelier Exit (Short, 3 ATRs) | 2.33 |
| Upper Bollinger Bands | 2.27 |
| Lower Bollinger Band | 1.33 |
| Percent B (%b) | 0.59 |
| BandWidth | 52.24 |
| MACD Line | 0.05 |
| MACD Signal Line | -0.01 |
| MACD Histogram | 0.0585 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.56 | ||||
| Resistance 3 (R3) | 2.62 | 2.45 | 2.45 | ||
| Resistance 2 (R2) | 2.45 | 2.28 | 2.42 | 2.41 | |
| Resistance 1 (R1) | 2.17 | 2.17 | 2.08 | 2.11 | 2.37 |
| Pivot Point | 2.00 | 2.00 | 1.96 | 1.97 | 2.00 |
| Support 1 (S1) | 1.71 | 1.82 | 1.63 | 1.65 | 1.39 |
| Support 2 (S2) | 1.54 | 1.72 | 1.51 | 1.35 | |
| Support 3 (S3) | 1.26 | 1.54 | 1.31 | ||
| Support 4 (S4) | 1.20 |
